2
Total Mentions
2
Documents
25
Connected Entities
Organization referenced in documents
nvened by the FDA to analyze the data on the drug. Some doctors argued its use should be restricted mainly to patients with FH. But Mark Schoenebaum, Evercore ISI’s pharmaceutical analyst, says that investors were initially disappointed because they had hoped the FDA would greenlight the drug for an even broader
Page: HOUSE_OVERSIGHT_025890 →nvened by the FDA to analyze the data on the drug. Some doctors argued its use should be restricted mainly to patients with FH. But Mark Schoenebaum, Evercore ISI’s pharmaceutical analyst, says that investors were initially disappointed because they had hoped the FDA would greenlight the drug for an even broader
Page: HOUSE_OVERSIGHT_026364 →
Jeffrey Epstein
PersonAmerican sex offender and financier (1953–2019)

Donald Trump
PersonPresident of the United States (2017–2021, 2025–present)

Pfizer
OrganizationAmerican multinational pharmaceutical and biotechnology corporation

Amgen
OrganizationAmerican multinational biopharmaceutical company

John Brennan
PersonDirector of the Central Intelligence Agency from 2013 to 2017

the Cleveland Clinic
OrganizationOrganization referenced in documents

the Food and Drug Administration
OrganizationOrganization referenced in documents

Sanford C. Bernstein
OrganizationOrganization referenced in documents
Sultan Bin Sulayern
PersonPerson referenced in documents

Matthew Herper
PersonName reference in documents
Nissen
PersonSurname or name fragment in documents

Troy Brennan
PersonAmerican businessperson
Leonard S. Schleifer
PersonName reference in documents

Mark Schoenebaum
PersonName reference in documents

Geoffrey Porges
PersonName reference in documents
Schleifer
PersonName reference in documents

Olivier Brandicourt
PersonFrench businessman
the Human Genome
OrganizationOrganization referenced in documents
Vioxx
OrganizationOrganization referenced in documents

CVS Caremark
OrganizationPrescription benefit management subsidiary of CVS Health